Cara Care receives seven million US dollars

The start-up now wants to expand into France. It is also getting a managing director.

The Berlin start-up Cara Care has raised seven million US dollars in a financing round. The main investor is the international food and nutrition manufacturer Dr. Schär AG. Previous investors are Sabadell Asabys and Johnson & Johnson Innovation.

Cara Care provides digital therapies for digestive health. The start-up was recently approved by the German Federal Institute for Drugs and Medical Devices as a prescribable digital therapeutic application (DiGA). This means that the costs of the therapy can be covered by health insurance companies.

The start-up now wants to accelerate its sales in the USA and drive forward its expansion into France and other European markets. It also wants to expand its portfolio of digital therapeutics.

James (Jim) Mapes is also joining the company as a new Managing Director. The experienced healthcare manager will work with founders Jesaja Brinkmann and Andre Sommer and Chief Operating Officer Felix Köhler to expand the start-up's platform. "We are thrilled to have Jim at the head of our team," says Brinkmann.